Spark Investment Management buys $14,746,455 stake in Chemours Co (CC)

Chemours Co (CC) : Spark Investment Management scooped up 495,100 additional shares in Chemours Co during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 12, 2016. The investment management firm now holds a total of 1,287,900 shares of Chemours Co which is valued at $14,746,455.Chemours Co makes up approximately 1.27% of Spark Investment Management’s portfolio.

Other Hedge Funds, Including , Delphi Private Advisors reduced its stake in CC by selling 3,901 shares or 99.59% in the most recent quarter. The Hedge Fund company now holds 16 shares of CC which is valued at $183. Armbruster Capital Management sold out all of its stake in CC during the most recent quarter. The investment firm sold 20 shares of CC which is valued $186.Bartlett reduced its stake in CC by selling 144 shares or 70.59% in the most recent quarter. The Hedge Fund company now holds 60 shares of CC which is valued at $570.Heritage Investors Management Corp reduced its stake in CC by selling 2,861 shares or 1.6% in the most recent quarter. The Hedge Fund company now holds 175,959 shares of CC which is valued at $1,645,217. Chemours Co makes up approx 0.12% of Heritage Investors Management Corp’s portfolio.

Chemours Co opened for trading at $12.68 and hit $13.42 on the upside on Monday, eventually ending the session at $13.27, with a gain of 4.82% or 0.61 points. The heightened volatility saw the trading volume jump to 26,58,417 shares. Company has a market cap of $2,409 M.

On the company’s financial health, Chemours Co reported $0.27 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on Aug 8, 2016. Analyst had a consensus of $0.17. The company had revenue of $1383.00 million for the quarter, compared to analysts expectations of $1418.96 million. The company’s revenue was down -8.3 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $-0.10 EPS.

The Chemours Company (Chemours) is a provider of performance chemicals. The Company delivers solutions with a range of industrial and specialty chemical products for markets including plastics and coatings refrigeration and air conditioning general industrial and mining and oil refining. The Company operates through three segments: Titanium Technologies Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2) under the brands including Ti-Pure and Vantage. Its Fluoroproducts segment is a provider of fluoroproducts under the brands including Suva ISCEON Freon Opteon Teflon Tefzel Viton Krytox Formacel Dymel FM 200 Nafion and Capstone. Its Chemical Solutions segment is a provider of industrial and specialty performance chemicals under the brands including Virkon and Oxone. The Company’s products include titanium dioxide refrigerants industrial fluoropolymer resins sodium cyanide sulfuric acid and aniline.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Chemours Co - Is it time to Sell?

Top Brokerage Firms are advising their investors on Chemours Co. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.